Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Colgate-Palmolive (CL)

Colgate-Palmolive adds Bristol Myers Squibb CEO Christopher Boerner to its board

Neutral Impact 3 of 5 leadership Written later

Colgate-Palmolive's board elected Christopher S. Boerner, chair and chief executive of Bristol Myers Squibb, as a director effective March 15, 2026. Separately, director Steven A. Cahillane will not stand for reelection at the May 8, 2026 annual meeting because of his new role as chief executive of The Kraft Heinz Company. The filing describes board composition changes only and gives no financial results or operating impact.

Key points

  • Christopher S. Boerner, 55, joins the board effective March 15, 2026; he has been Bristol Myers Squibb CEO since November 2023 and board chair since April 2024
  • Steven A. Cahillane will not seek reelection to the board at the Annual Meeting of Stockholders on May 8, 2026
  • Cahillane cited the demands of his new position as CEO of The Kraft Heinz Company
  • Boerner will receive non-employee director compensation under the program described in the March 26, 2025 proxy statement

The filing

CompanyColgate-Palmolive (CL)
Form8-K, current report
Filed with the SECMar 12, 2026, 4:33 PM ET
Accession number0000021665-26-000008

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 12, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.